Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Manzano-Muñoz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2019
A New CDK9 Inhibitor on the Block to Treat Hematologic MalignanciesClara Alcon, Albert Manzano-Muñoz, Joan Montero
Methods in Molecular Biology (Clifton, N.J.)|December 9, 2023
A New Microfluidic Device to Facilitate Functional Precision Medicine AssaysAlbert Manzano-Muñoz, Jose Yeste, María A Ortega, et al.
Frontiers in Cell and Developmental Biology|September 27, 2021
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic LeukemiaAlbert Manzano-Muñoz, Clara Alcon, Pablo Menéndez, et al.
Cell Death & Disease|August 18, 2020
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistanceClara Alcon, Albert Manzano-Muñoz, Estela Prada, et al.
NPJ Precision Oncology|December 1, 2022
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacyAlbert Manzano-Muñoz, José Yeste, María A Ortega, et al.
Cell Death & Disease|March 21, 2025
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancerFernando Martín, Clara Alcon, Elba Marín, et al.
Frontiers in Pediatrics|October 6, 2023
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)Pablo Velasco, Francisco Bautista, Alba Rubio, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2019
A New CDK9 Inhibitor on the Block to Treat Hematologic MalignanciesClara Alcon, Albert Manzano-Muñoz, Joan Montero
Methods in Molecular Biology (Clifton, N.J.)|December 9, 2023
A New Microfluidic Device to Facilitate Functional Precision Medicine AssaysAlbert Manzano-Muñoz, Jose Yeste, María A Ortega, et al.
Frontiers in Cell and Developmental Biology|September 27, 2021
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic LeukemiaAlbert Manzano-Muñoz, Clara Alcon, Pablo Menéndez, et al.
Cell Death & Disease|August 18, 2020
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistanceClara Alcon, Albert Manzano-Muñoz, Estela Prada, et al.
NPJ Precision Oncology|December 1, 2022
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacyAlbert Manzano-Muñoz, José Yeste, María A Ortega, et al.
Cell Death & Disease|March 21, 2025
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancerFernando Martín, Clara Alcon, Elba Marín, et al.
Frontiers in Pediatrics|October 6, 2023
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)Pablo Velasco, Francisco Bautista, Alba Rubio, et al.
Pageof 1